Souhaitez-vous accéder aux communiqués récents ?

MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress YAVNE, Israel, September 2, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global...

MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...

ZAVENTEM, Belgium, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Comunicado completo disponible aquí: https://www.etexgroup.com/en/news/2571873/ Los resultados financieros de Etex en el primer semestre...

ZAVENTEM, België, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Volledig persbericht: https://www.etexgroup.com/nl-be/Nieuws/2571873/ De financiële prestaties van Etex op halfjaarbasis tonen een...

ZAVENTEM, Belgien, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Die vollständige Pressemitteilung finden Sie hier: https://www.etexgroup.com/en/news/2571873/ Die Finanzergebnisse von Etex zum Halbjahr...

ZAVENTEM, Belgique, 01 sept. 2025 (GLOBE NEWSWIRE) -- Communiqué complet : https://www.etexgroup.com/fr-be/actualites/2571873/ La performance financière d’Etex pour le premier semestre montre une...

ZAVENTEM, Belgium, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Full release available here: https://www.etexgroup.com/en/news/2571873/ Etex’s financial performance at half-year shows significant...

Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology New...

Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to Host Investor Event...

Tidewave Bio completes FDA INTERACT meeting for TBC-1, advancing its universal cell therapy toward pre-IND and IND/CTA to address solid tumors.